Estrogen and Progestin (Oral Contraceptives)

Generic name: Pronounced as (ess' troe jen) (proe jes tin)

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 09/15/2015

Cigarette smoking increases the risk of serious side effects from oral contraceptives, including heart attacks, blood clots, and strokes. This risk is higher for women over 35 years of age and heavy smokers (15 or more cigarettes per day). If you take oral contraceptives, you should not smoke.

Oral contraceptives (birth-control pills) are used to prevent pregnancy. Estrogen and progestin are two female sex hormones. Combinations of estrogen and progestin work by preventing ovulation (the release of eggs from the ovaries). They also change the lining of the uterus (womb) to prevent pregnancy from developing and change the mucus at the cervix (opening of the uterus) to prevent sperm (male reproductive cells) from entering. Oral contraceptives are a very effective method of birth control, but they do not prevent the spread of human immunodeficiency virus (HIV, the virus that causes acquired immunodeficiency syndrome [AIDS]) and other sexually transmitted diseases.

Some brands of oral contraceptives are also used to treat acne in certain patients. Oral contraceptives treat acne by decreasing the amounts of certain natural substances that can cause acne.

Some oral contraceptives (Beyaz, Yaz) are also used to relieve the symptoms of premenstrual dysphoric disorder (physical and emotional symptoms that occur before the menstrual period each month) in women who have chosen to use an oral contraceptive to prevent pregnancy.

Oral contraceptives come in packets of 21, 28, or 91 tablets to take by mouth once a day, every day or almost every day of a regular cycle. To avoid nausea, take oral contraceptives with food or milk. Take your oral contraceptive at the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take your oral contraceptive exactly as directed. Do not take more or less of it, take it more often, or take it for a longer time than prescribed by your doctor.

Oral contraceptives come in many different brands. Different brands of oral contraceptives contain slightly different medications or doses, are taken in slightly different ways, and have different risks and benefits. Be sure that you know which brand of oral contraceptives you are using and exactly how you should use it. Ask your doctor or pharmacist for a copy of the manufacturer's information for the patient and read it carefully.

If you have a 21-tablet packet, take 1 tablet daily for 21 days and then none for 7 days. Then start a new packet.

If you have a 28-tablet packet, take 1 tablet daily for 28 days in a row in the order specified in your packet. Start a new packet the day after you take your 28th tablet. The tablets in most 28-tablet packets may have different colors. Many 28-tablet packets have certain color tablets that contain different amounts of estrogen and progestin, but also may have other color tablets which contain an inactive ingredient or a folate supplement.

If you have a 91-day tablet packet, take 1 tablet daily for 91 days. Your packet will contain three trays of tablets. Start with the first tablet on the first tray and continue taking 1 tablet every day in the order specified on the packet until you have taken all of the tablets on all of the trays. The last set of tablets are a different color. These tablets may contain an inactive ingredient, or they may contain a very low dose of estrogen. Start your new packet the day after you take your 91st tablet.

Your doctor will tell you when you should start taking your oral contraceptive. Oral contraceptives are usually started on the first or fifth day of your menstrual period or on the first Sunday after or on which bleeding begins. Your doctor will also tell you whether you need to use another method of birth control during the first 7 to 9 days that you take your oral contraceptive and will help you choose a method. Follow these directions carefully.

You will probably experience withdrawal bleeding similar to a menstrual period while you are taking the inactive tablets or the low dose estrogen tablets or during the week that you do not take your oral contraceptive. If you are taking the type of packet that only contains active tablets, you will not experience any scheduled bleeding, but you may experience unexpected bleeding and spotting, especially at the beginning of your treatment. Be sure to start taking your new packet on schedule even if you are still bleeding.

You may need to use a backup method of birth control if you vomit or have diarrhea while you are taking an oral contraceptive. Talk to your doctor about this before you begin to take your oral contraceptive so that you can prepare a backup method of birth control in case it is needed. If you vomit or have diarrhea while you are taking an oral contraceptive, call your doctor to find out how long you should use the backup method.

If you have recently given birth, wait until 4 weeks after delivery to begin taking oral contraceptives. If you have had an abortion or miscarriage, talk to your doctor about when you should begin taking oral contraceptives.

Oral contraceptives will work only as long as they are taken regularly. Continue to take oral contraceptives every day even if you are spotting or bleeding, have an upset stomach, or do not think that you are likely to become pregnant. Do not stop taking oral contraceptives without talking to your doctor.

Oral contraceptives are also sometimes used to treat heavy or irregular menstruation and endometriosis (a condition in which the type of tissue that lines the uterus [womb] grows in other areas of the body and causes pain, heavy or irregular menstruation [periods], and other symptoms). Talk to your doctor about the risks of using this medication for your condition.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking oral contraceptives,

  • tell your doctor and pharmacist if you are allergic to estrogen, progestin, or any other medications.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, and nutritional supplements you are taking. Be sure to mention any of the following: acetaminophen (APAP, Tylenol); antibiotics such as ampicillin (Principen), clarithromycin (Biaxin),erythromycin (E.E.S., E-Mycin, Erythrocin), isoniazid (INH, Nydrazid), metronidazole (Flagyl),minocycline (Dynacin, Minocin), rifabutin (Mycobutin), rifampin (Rifadin, Rimactane), tetracycline (Sumycin), and troleandomycin (TAO) (not available in the U.S.); anticoagulants ('blood thinners') such as warfarin (Coumadin); antifungals such as griseofulvin (Fulvicin, Grifulvin, Grisactin), fluconazole (Diflucan), itraconazole (Sporanox), and ketoconazole (Nizoral); atorvastatin (Lipitor); clofibrate (Atromid-S); cyclosporine (Neoral, Sandimmune); bosentan (Tracleer); cimetidine (Tagamet); danazol (Danocrine); delavirdine (Rescriptor); diltiazem (Cardizem, Dilacor, Tiazac); fluoxetine (Prozac, Sarafem, in Symbyax); HIV protease inhibitors such as indinavir (Crixivan) and ritonavir (Norvir); medications for seizures such as carbamazepine (Tegretol), felbamate (Felbatol), lamotrigine (Lamictal), oxcarbazepine (Trileptal), phenobarbital (Luminal, Solfoton), phenytoin (Dilantin), primidone (Mysoline), and topiramate (Topamax); modafinil (Provigil); morphine (Kadian, MS Contin, MSIR, others); nefazodone; rifampin (Rimactane, in Rifadin, in Rifater); oral steroids such as dexamethasone (Decadron, Dexone), methylprednisolone (Medrol), prednisone (Deltasone), and prednisolone (Prelone); temazepam (Restoril); theophylline (Theobid, Theo-Dur); thyroid medication such as levothyroxine (Levothroid, Levoxyl, Synthroid); verapamil (Calan, Covera, Isoptin, Verelan); vitamin C; and zafirlukast (Accolate). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • if you are taking oral contraceptives that contain drosperinone (Beyaz, Gianvi, Loryna, Ocella, Safyral, Syeda, Yasmin, Yaz, and Zarah) tell your doctor and pharmacist if you are taking any of the medications listed above or any of the following: angiotensin-converting enzyme (ACE) inhibitors such as benazepril (Lotensin), enalapril (Vasotec), and lisinopril (Prinivil, Zestril); angiotensin II antagonists such as irbesartan (Avapro), losartan (Cozaar), and valsartan (Diovan); aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn); diuretics ('water pills') such as amiloride (Midamor), spironolactone (Aldactone), and triamterene (Dyrenium); eplerenone (Inspra); heparin; or potassium supplements. Before taking Beyaz or Safyral, also tell your doctor or pharmacist if you are taking cholestyramine (Locholest, Prevalite, Questran), a folate supplement, methotrexate (Trexall), pyrimethamine (Daraprim), sulfasalazine (Azulfidine), or valproic acid (Depakene, Stavzor).

  • tell your doctor what herbal products you are taking, especially St. John's wort.

  • tell your doctor if you have or have ever had blood clots in your legs, lungs, or eyes; thrombophilia (condition in which the blood clots easily); coronary artery disease (clogged blood vessels leading to the heart); cerebrovascular disease (clogging or weakening of the blood vessels within the brain or leading to the brain); stroke or mini-stroke; an irregular heartbeat; heart disease; a heart attack; chest pain; diabetes that has affected your circulation; headaches that come along with other symptoms such as vision changes, weakness, and dizziness; high blood pressure; breast cancer; cancer of the lining of the uterus, cervix, or vagina; liver cancer, liver tumors, or other types of liver disease; yellowing of the skin or eyes during pregnancy or while you were using hormonal contraceptives (birth control pills, patches, rings, implants, or injections); unexplained abnormal vaginal bleeding; adrenal insufficiency (condition in which the body does not produce enough of certain natural substances needed for important functions such as blood pressure); or kidney disease. Also tell your doctor if you have recently had surgery or have been unable to move around for any reason. Your doctor may tell you that you should not take certain types of oral contraceptives or that you should not take any type of oral contraceptive if you have or have had any of these conditions.

  • Also tell your doctor if anyone in your family has had breast cancer, if you are overweight, and if you have or have ever had problems with your breasts such as lumps, an abnormal mammogram (breast x-ray), or fibrocystic breast disease (swollen, tender breasts and/or breast lumps that are not cancer); high blood cholesterol or fats; diabetes; asthma; toxemia (high blood pressure during pregnancy); heart attack; chest pain; seizures; migraine headaches; depression; gallbladder disease; jaundice (yellowing of the skin or eyes); and excessive weight gain and fluid retention (bloating) during the menstrual cycle.

  • do not take oral contraceptives if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking oral contraceptives, call your doctor immediately.

  • if you miss periods while you are taking oral contraceptives, you may be pregnant. If you are using a 91-tablet packet and you miss one period, call your doctor. If you are using another type of packet according to the directions and you miss one period, you may continue to take your tablets. However, if you have not taken your tablets as directed and you miss one period or if you have taken your tablets as directed and you miss two periods, call your doctor and use another method of birth control until you have a pregnancy test. If you are using a 28-tablet packet that contains only active tablets, you will not expect to have periods on a regular basis, so it may be hard to tell if you are pregnant. If you are using this type of oral contraceptive, call your doctor and have a pregnancy test if you experience symptoms of pregnancy such as nausea, vomiting, and breast tenderness, or if you suspect you may be pregnant.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking oral contraceptives.

  • you should know that oral contraceptives may cause a spotty darkening of the skin, especially on the face. If you have experienced changes in your skin color during pregnancy or while you were taking oral contraceptives in the past, you should avoid exposure to real or artificial sunlight while you are taking oral contraceptives. Wear protective clothing, sunglasses, and sunscreen.

  • tell your doctor and pharmacist if you wear contact lenses. If you notice changes in vision or ability to wear your lenses while taking oral contraceptives, see an eye doctor.

Unless your doctor tells you otherwise, continue your normal diet.

If you miss doses of your oral contraceptive, you may not be protected from pregnancy. You may need to use a backup method of birth control for 7 to 9 days or until the end of the cycle. Every brand of oral contraceptives comes with specific directions to follow if you miss one or more doses. Carefully read the directions in the manufacturer's information for the patient that came with your oral contraceptive. If you have any questions, call your doctor or pharmacist. Continue to take your tablets as scheduled and use a backup method of birth control until your questions are answered.

  • Oral contraceptives may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • nausea

    • vomiting

    • stomach cramps or bloating

    • diarrhea

    • constipation

    • gingivitis (swelling of the gum tissue)

    • increased or decreased appetite

    • weight gain or weight loss

    • brown or black skin patches

    • acne

    • hair growth in unusual places

    • bleeding or spotting between menstrual periods

    • changes in menstrual flow

    • painful or missed periods

    • breast tenderness, enlargement, or discharge

    • swelling, redness, irritation, burning, or itching of the vagina

    • white vaginal discharge

  • Some side effects can be serious. The following symptoms are uncommon, but if you experience any of them, call your doctor immediately:

    • severe headache

    • severe vomiting

    • speech problems

    • dizziness or faintness

    • weakness or numbness of an arm or leg

    • crushing chest pain or chest heaviness

    • coughing up blood

    • shortness of breath

    • leg pain

    • partial or complete loss of vision

    • double vision

    • bulging eyes

    • severe stomach pain

    • yellowing of the skin or eyes

    • loss of appetite

    • extreme tiredness, weakness, or lack of energy

    • fever

    • dark-colored urine

    • light-colored stool

    • swelling of the hands, feet, ankles, or lower legs

    • depression, especially if you also have trouble sleeping, tiredness, loss of energy, or other mood changes

    • unusual bleeding

    • rash

    • menstrual bleeding that is unusually heavy or that lasts for longer than 7 days in a row

  • Oral contraceptives may increase the chance that you will develop liver tumors. These tumors are not a form of cancer, but they can break and cause serious bleeding inside the body. Oral contraceptives may also increase the chance that you will develop breast or liver cancer, or have a heart attack, a stroke, or a serious blood clot. Talk to your doctor about the risks of using oral contraceptives.

  • Some studies show that women who take oral contraceptives that contain drosperinone (Beyaz, Gianvi, Loryna, Ocella, Safyral, Syeda, Yasmin, Yaz, and Zarah) may be more likely to develop deep vein thrombosis (a serious or life-threatening condition in which blood clots that form in the veins, usually in the legs and may move through the body to the lungs) than women who take oral contraceptives that do not contain drosperinone. However, other studies do not show this increased risk. Before you begin taking oral contraceptives, talk to your doctor about the risk that you will develop blood clots and about which oral contraceptive or other method of birth control may be the best choice for you.

  • Oral contraceptives may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the packet it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

  • nausea

  • vaginal bleeding

Keep all appointments with your doctor and the laboratory. You should have a complete physical examination every year, including blood pressure measurements, breast and pelvic exams, and a Pap test. Follow your doctor's directions for examining your breasts; report any lumps immediately.

Before you have any laboratory tests, tell the laboratory personnel that you take oral contraceptives.

If you wish to stop taking oral contraceptives and become pregnant, your doctor may tell you to use another method of birth control until you begin to menstruate regularly again. It may take a long time for you to become pregnant after you stop taking oral contraceptives, especially if you have never had a baby or if you had irregular, infrequent, or complete absence of menstrual periods before taking oral contraceptives. However, it is possible to become pregnant within days of stopping certain oral contraceptives. If you want to stop taking oral contraceptives but do not want to become pregnant, you should begin using another type of birth control as soon as you stop taking oral contraceptives. Discuss any questions that you may have with your doctor.

Oral contraceptives may decrease the amount of folate in your body. Folate is important for the development of a healthy baby, so you should talk to your doctor if you want to become pregnant soon after you stop taking oral contraceptives. Your doctor may recommend that you take a folate supplement or an oral contraceptive that contains a folate supplement (Beyaz, Safyral).

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

  • Apri® (containing Desogestrel, Ethinyl Estradiol)
  • Aranelle® (containing Ethinyl Estradiol, Norethindrone)
  • Aviane® (containing Ethinyl Estradiol, Levonorgestrel)
  • Azurette® (containing Desogestrel, Ethinyl Estradiol)
  • Balziva® (containing Ethinyl Estradiol, Norethindrone)
  • Beyaz® (containing Drospirenone, Ethinyl Estradiol, Levomefolate)
  • Brevicon® (containing Ethinyl Estradiol, Norethindrone)
  • Camrese Lo® (containing Ethinyl Estradiol, Levonorgestrel)
  • Camrese® (containing Ethinyl Estradiol, Levonorgestrel)
  • Cesia® (containing Desogestrel, Ethinyl Estradiol)
  • Cryselle® (containing Ethinyl Estradiol, Norgestrel)
  • Cyclessa® (containing Desogestrel, Ethinyl Estradiol)
  • Demulen® (containing Ethynodiol, Ethinyl Estradiol)
  • Desogen® (containing Desogestrel, Ethinyl Estradiol)
  • Enpresse® (containing Ethinyl Estradiol, Levonorgestrel)
  • Estrostep® Fe (containing Ethinyl Estradiol, Norethindrone)
  • Femcon® Fe (containing Ethinyl Estradiol, Norethindrone)
  • Gianvi® (containing Drospirenone, Ethinyl Estradiol)
  • Jolessa® (containing Ethinyl Estradiol, Levonorgestrel)
  • Junel® (containing Ethinyl Estradiol, Norethindrone)
  • Junel® Fe (containing Ethinyl Estradiol, Norethindrone)
  • Kariva® (containing Desogestrel, Ethinyl Estradiol)
  • Kelnor® (containing Ethynodiol, Ethinyl Estradiol)
  • Leena® (containing Ethinyl Estradiol, Norethindrone)
  • Lessina® (containing Ethinyl Estradiol, Levonorgestrel)
  • Levlen® (containing Ethinyl Estradiol, Levonorgestrel)
  • Levlite® (containing Ethinyl Estradiol, Levonorgestrel)
  • Levora® (containing Ethinyl Estradiol, Levonorgestrel)
  • Lo/Ovral® (containing Ethinyl Estradiol, Norgestrel)
  • Loestrin® (containing Ethinyl Estradiol, Norethindrone)
  • Loestrin® Fe (containing Ethinyl Estradiol, Norethindrone)
  • Loryna® (containing Drospirenone, Ethinyl Estradiol)
  • LoSeasonique® (containing Ethinyl Estradiol, Levonorgestrel)
  • Low-Ogestrel® (containing Ethinyl Estradiol, Norgestrel)
  • Lutera® (containing Ethinyl Estradiol, Levonorgestrel)
  • Lybrel® (containing Ethinyl Estradiol, Levonorgestrel)
  • Microgestin® (containing Ethinyl Estradiol, Norethindrone)
  • Microgestin® Fe (containing Ethinyl Estradiol, Norethindrone)
  • Mircette® (containing Desogestrel, Ethinyl Estradiol)
  • Modicon® (containing Ethinyl Estradiol, Norethindrone)
  • MonoNessa® (containing Ethinyl Estradiol, Norgestimate)
  • Natazia® (containing estradiol valerate and dienogest)
  • Necon® 0.5/35 (containing Ethinyl Estradiol, Norethindrone)
  • Necon® 1/50 (containing Mestranol, Norethindrone)
  • Nordette® (containing Ethinyl Estradiol, Levonorgestrel)
  • Norinyl® 1+35 (containing Ethinyl Estradiol, Norethindrone)
  • Norinyl® 1+50 (containing Mestranol, Norethindrone)
  • Nortrel® (containing Ethinyl Estradiol, Norethindrone)
  • Ocella® (containing Drospirenone, Ethinyl Estradiol)
  • Ogestrel® (containing Ethinyl Estradiol, Norgestrel)
  • Ortho Tri-Cyclen® (containing Ethinyl Estradiol, Norgestimate)
  • Ortho Tri-Cyclen® Lo (containing Ethinyl Estradiol, Norgestimate)
  • Ortho-Cept® (containing Desogestrel, Ethinyl Estradiol)
  • Ortho-Cyclen® (containing Ethinyl Estradiol, Norgestimate)
  • Ortho-Novum® 1/35 (containing Ethinyl Estradiol, Norethindrone)
  • Ortho-Novum® 1/50 [DSC] (containing Mestranol, Norethindrone)
  • Ovcon® (containing Ethinyl Estradiol, Norethindrone)
  • Portia® (containing Ethinyl Estradiol, Levonorgestrel)
  • Previfem® [DSC] (containing Ethinyl Estradiol, Norgestimate)
  • Quasense® (containing Ethinyl Estradiol, Levonorgestrel)
  • Reclipsen® (containing Desogestrel, Ethinyl Estradiol)
  • Safyral® (containing Drospirenone, Ethinyl Estradiol, Levomefolate)
  • Seasonale® (containing Ethinyl Estradiol, Levonorgestrel)
  • Seasonique® (containing Ethinyl Estradiol, Levonorgestrel)
  • Solia® (containing Desogestrel, Ethinyl Estradiol)
  • Sprintec® (containing Ethinyl Estradiol, Norgestimate)
  • Sronyx® (containing Ethinyl Estradiol, Levonorgestrel)
  • Syeda® (containing Drospirenone, Ethinyl Estradiol)
  • Tilia® Fe (containing Ethinyl Estradiol, Norethindrone)
  • Tri-Legest® Fe (containing Ethinyl Estradiol, Norethindrone)
  • Tri-Norinyl® (containing Ethinyl Estradiol, Norethindrone)
  • Tri-Previfem® [DSC] (containing Ethinyl Estradiol, Norgestimate)
  • Tri-Sprintec® (containing Ethinyl Estradiol, Norgestimate)
  • TriNessa® (containing Ethinyl Estradiol, Norgestimate)
  • Triphasil® (containing Ethinyl Estradiol, Levonorgestrel)
  • Trivora® (containing Ethinyl Estradiol, Levonorgestrel)
  • Velivet® (containing Desogestrel, Ethinyl Estradiol)
  • Yasmin® (containing Drospirenone, Ethinyl Estradiol)
  • Yaz® (containing Drospirenone, Ethinyl Estradiol)
  • Zarah® (containing Drospirenone, Ethinyl Estradiol)
  • Zenchent® (containing Ethinyl Estradiol, Norethindrone)
  • Zeosa® Fe (containing Ethinyl Estradiol, Norethindrone)
  • Zovia® (containing Ethynodiol, Ethinyl Estradiol)

  • Birth-control pills

Drug Interaction
Moxifloxacin Moxifloxacin The metabolism of Conjugated estrogens can be decreased when combined with Moxifloxacin.
Repaglinide Repaglinide The excretion of Repaglinide can be decreased when combined with Conjugated estrogens.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The metabolism of Conjugated estrogens can be increased when combined with Insulin glargine.
Leflunomide Leflunomide The serum concentration of Conjugated estrogens can be decreased when it is combined with Leflunomide.
Nevirapine Nevirapine The metabolism of Conjugated estrogens can be decreased when combined with Nevirapine.
Atorvastatin Atorvastatin The excretion of Atorvastatin can be decreased when combined with Conjugated estrogens.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Conjugated estrogens.
Anagrelide Anagrelide The metabolism of Conjugated estrogens can be decreased when combined with Anagrelide.
Candesartan Candesartan The excretion of Conjugated estrogens can be decreased when combined with Candesartan.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Conjugated estrogens.
Clopidogrel Clopidogrel The metabolism of Clopidogrel can be decreased when combined with Conjugated estrogens.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The excretion of Conjugated estrogens can be decreased when combined with Erythromycin.
Fenofibrate Fenofibrate Conjugated estrogens may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
Guanfacine Guanfacine Conjugated estrogens may decrease the excretion rate of Guanfacine which could result in a higher serum level.
Magnesium Hydroxide Magnesium Hydroxide Conjugated estrogens may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Mycophenolate Mycophenolate Conjugated estrogens may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
Olsalazine Olsalazine Olsalazine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Potassium Potassium Potassium may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone The serum concentration of Prednisone can be increased when it is combined with Conjugated estrogens.
Ranitidine Ranitidine The excretion of Ranitidine can be decreased when combined with Conjugated estrogens.
Reserpine Reserpine Reserpine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Rizatriptan Rizatriptan Conjugated estrogens may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
Sumatriptan Sumatriptan Conjugated estrogens may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
Tacrolimus Tacrolimus Tacrolimus may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Tizanidine Tizanidine The serum concentration of Tizanidine can be increased when it is combined with Conjugated estrogens.
Triamcinolone Triamcinolone The serum concentration of Triamcinolone can be increased when it is combined with Conjugated estrogens.
Zolmitriptan Zolmitriptan The metabolism of Zolmitriptan can be decreased when combined with Conjugated estrogens.
Ampicillin Injection Ampicillin Injection Conjugated estrogens may decrease the excretion rate of Ampicillin which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Doxycycline may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Famotidine Injection Famotidine Injection The excretion of Famotidine can be decreased when combined with Conjugated estrogens.
Fluconazole Injection Fluconazole Injection Fluconazole may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Foscarnet Injection Foscarnet Injection Foscarnet may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Hydromorphone Injection Hydromorphone Injection Conjugated estrogens may decrease the excretion rate of Hydromorphone which could result in a higher serum level.
Interferon Beta-1b Injection Interferon Beta-1b Injection The metabolism of Conjugated estrogens can be decreased when combined with Interferon beta-1b.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The metabolism of Conjugated estrogens can be decreased when combined with Interferon gamma-1b.
Levofloxacin Injection Levofloxacin Injection The metabolism of Conjugated estrogens can be decreased when combined with Levofloxacin.
Meperidine Injection Meperidine Injection The metabolism of Conjugated estrogens can be increased when combined with Meperidine.
Methylprednisolone Injection Methylprednisolone Injection The serum concentration of Methylprednisolone can be increased when it is combined with Conjugated estrogens.
Metoclopramide Injection Metoclopramide Injection The metabolism of Metoclopramide can be decreased when combined with Conjugated estrogens.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Conjugated estrogens may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection Zidovudine Injection The excretion of Zidovudine can be decreased when combined with Conjugated estrogens.
Altretamine Altretamine Amphetamine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cyclosporine Cyclosporine Cyclosporine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ondansetron Ondansetron The metabolism of Conjugated estrogens can be decreased when combined with Ondansetron.
Enoxaparin Injection Enoxaparin Injection Conjugated estrogens may decrease the anticoagulant activities of Enoxaparin.
Torsemide Torsemide Torasemide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Olanzapine Olanzapine The metabolism of Olanzapine can be decreased when combined with Conjugated estrogens.
Alosetron Alosetron The metabolism of Conjugated estrogens can be decreased when combined with Alosetron.
Entacapone Entacapone The metabolism of Conjugated estrogens can be decreased when combined with Entacapone.
Eprosartan Eprosartan The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Eprosartan.
Meloxicam Meloxicam Meloxicam may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Pantoprazole Pantoprazole The excretion of Conjugated estrogens can be decreased when combined with Pantoprazole.
Telmisartan Telmisartan Telmisartan may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Temozolomide Temozolomide Conjugated estrogens may decrease the excretion rate of Temozolomide which could result in a higher serum level.
Zaleplon Zaleplon Conjugated estrogens may decrease the excretion rate of Zaleplon which could result in a higher serum level.
Anakinra Anakinra The metabolism of Conjugated estrogens can be increased when combined with Anakinra.
Pentosan Polysulfate Pentosan Polysulfate Conjugated estrogens may decrease the anticoagulant activities of Pentosan polysulfate.
Trimipramine Trimipramine The serum concentration of Trimipramine can be increased when it is combined with Conjugated estrogens.
Etanercept Injection Etanercept Injection The metabolism of Conjugated estrogens can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Conjugated estrogens can be increased when combined with Armodafinil.
Perindopril Perindopril The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Perindopril.
Tenofovir Tenofovir Tenofovir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Sirolimus Sirolimus The risk or severity of angioedema can be increased when Sirolimus is combined with Conjugated estrogens.
Eplerenone Eplerenone Eplerenone may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Zonisamide Zonisamide Conjugated estrogens may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.
Adalimumab Injection Adalimumab Injection The metabolism of Conjugated estrogens can be increased when combined with Adalimumab.
Atomoxetine Atomoxetine Conjugated estrogens may decrease the excretion rate of Atomoxetine which could result in a higher serum level.
Ezetimibe Ezetimibe The excretion of Ezetimibe can be decreased when combined with Conjugated estrogens.
Atazanavir Atazanavir Atazanavir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Almotriptan Almotriptan Conjugated estrogens may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Omalizumab Injection Omalizumab Injection Conjugated estrogens may increase the thrombogenic activities of Omalizumab.
Rosuvastatin Rosuvastatin The excretion of Rosuvastatin can be decreased when combined with Conjugated estrogens.
Emtricitabine Emtricitabine Conjugated estrogens may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Interferon Beta-1a Subcutaneous Injection Interferon Beta-1a Subcutaneous Injection The metabolism of Conjugated estrogens can be decreased when combined with Interferon beta-1a.
Memantine Memantine Conjugated estrogens may decrease the excretion rate of Memantine which could result in a higher serum level.
Tegaserod Tegaserod The metabolism of Conjugated estrogens can be decreased when combined with Tegaserod.
Tadalafil Tadalafil Conjugated estrogens may decrease the excretion rate of Tadalafil which could result in a higher serum level.
Frovatriptan Frovatriptan The metabolism of Frovatriptan can be decreased when combined with Conjugated estrogens.
Gemifloxacin Gemifloxacin The metabolism of Conjugated estrogens can be decreased when combined with Gemifloxacin.
Progesterone Progesterone Progesterone may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Infliximab Injection Infliximab Injection The metabolism of Conjugated estrogens can be increased when combined with Infliximab.
Protriptyline Protriptyline The serum concentration of Protriptyline can be increased when it is combined with Conjugated estrogens.
Duloxetine Duloxetine The metabolism of Duloxetine can be decreased when combined with Conjugated estrogens.
Tinidazole Tinidazole Conjugated estrogens may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Bosentan Bosentan The excretion of Bosentan can be decreased when combined with Conjugated estrogens.
Cefditoren Cefditoren The excretion of Cefdinir can be decreased when combined with Conjugated estrogens.
Cinacalcet Cinacalcet The metabolism of Cinacalcet can be decreased when combined with Conjugated estrogens.
Natalizumab Injection Natalizumab Injection Conjugated estrogens may increase the thrombogenic activities of Natalizumab.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Erlotinib Erlotinib The metabolism of Conjugated estrogens can be decreased when combined with Erlotinib.
Eszopiclone Eszopiclone Conjugated estrogens may decrease the excretion rate of Eszopiclone which could result in a higher serum level.
Ganciclovir Ganciclovir The excretion of Ganciclovir can be decreased when combined with Conjugated estrogens.
Ribavirin Ribavirin Conjugated estrogens may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Valganciclovir Valganciclovir Conjugated estrogens may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Adefovir Adefovir Adefovir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine Amphetamine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Entecavir Entecavir The metabolism of Entecavir can be decreased when combined with Conjugated estrogens.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The metabolism of Conjugated estrogens can be decreased when combined with Peginterferon alfa-2a.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The serum concentration of Conjugated estrogens can be increased when it is combined with Peginterferon alfa-2b.
Ramelteon Ramelteon The metabolism of Ramelteon can be decreased when combined with Conjugated estrogens.
Fentanyl Fentanyl Conjugated estrogens may decrease the excretion rate of Fentanyl which could result in a higher serum level.
Pregabalin Pregabalin The risk or severity of angioedema can be increased when Pregabalin is combined with Conjugated estrogens.
Deferasirox Deferasirox The serum concentration of Conjugated estrogens can be increased when it is combined with Deferasirox.
Phenylephrine Phenylephrine The metabolism of Conjugated estrogens can be increased when combined with Phenylephrine.
Tipranavir Tipranavir The excretion of Conjugated estrogens can be decreased when combined with Tipranavir.
Ranolazine Ranolazine Ranolazine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Abatacept Injection Abatacept Injection The metabolism of Conjugated estrogens can be increased when combined with Abatacept.
Rasagiline Rasagiline The metabolism of Rasagiline can be decreased when combined with Conjugated estrogens.
Imatinib Imatinib Imatinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Sitagliptin Sitagliptin The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Sitagliptin.
Varenicline Varenicline Conjugated estrogens may decrease the excretion rate of Varenicline which could result in a higher serum level.
Bevacizumab Injection Bevacizumab Injection Conjugated estrogens may increase the thrombogenic activities of Bevacizumab.
Gefitinib Gefitinib Gefitinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Albuterol Albuterol Conjugated estrogens may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone Paliperidone Conjugated estrogens may decrease the excretion rate of Paliperidone which could result in a higher serum level.
Exemestane Exemestane The therapeutic efficacy of Exemestane can be decreased when used in combination with Conjugated estrogens.
Bortezomib Bortezomib The metabolism of Bortezomib can be decreased when combined with Conjugated estrogens.
Clofarabine Injection Clofarabine Injection The excretion of Clofarabine can be decreased when combined with Conjugated estrogens.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The metabolism of Conjugated estrogens can be increased when combined with Insulin glulisine.
Lubiprostone Lubiprostone Conjugated estrogens may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Primaquine Primaquine The metabolism of Primaquine can be increased when combined with Conjugated estrogens.
Rituximab Injection Rituximab Injection Conjugated estrogens may increase the thrombogenic activities of Rituximab.
Cetuximab Injection Cetuximab Injection Conjugated estrogens may increase the thrombogenic activities of Cetuximab.
Darunavir Darunavir The excretion of Conjugated estrogens can be decreased when combined with Darunavir.
Pemetrexed Injection Pemetrexed Injection Conjugated estrogens may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Ranibizumab Injection Ranibizumab Injection Conjugated estrogens may increase the thrombogenic activities of Ranibizumab.
Sorafenib Sorafenib The metabolism of Conjugated estrogens can be decreased when combined with Sorafenib.
Sunitinib Sunitinib Sunitinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Dronabinol Dronabinol Dronabinol may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Levocetirizine Levocetirizine Conjugated estrogens may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
Pegaptanib Injection Pegaptanib Injection Conjugated estrogens may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib Dasatinib The metabolism of Conjugated estrogens can be decreased when combined with Dasatinib.
Mexiletine Mexiletine The metabolism of Conjugated estrogens can be decreased when combined with Mexiletine.
Panitumumab Injection Panitumumab Injection Conjugated estrogens may increase the thrombogenic activities of Panitumumab.
Armodafinil Armodafinil The metabolism of Conjugated estrogens can be increased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection Conjugated estrogens may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Ivermectin Ivermectin The excretion of Conjugated estrogens can be decreased when combined with Ivermectin.
Temsirolimus Temsirolimus The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Temsirolimus.
Lenalidomide Lenalidomide Conjugated estrogens may increase the thrombogenic activities of Lenalidomide.
Nilotinib Nilotinib Nilotinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Budesonide Budesonide The serum concentration of Budesonide can be increased when it is combined with Conjugated estrogens.
Desmopressin Desmopressin Desmopressin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Doripenem Injection Doripenem Injection The excretion of Doripenem can be decreased when combined with Conjugated estrogens.
Arsenic Trioxide Injection Arsenic Trioxide Injection Conjugated estrogens may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
Desvenlafaxine Desvenlafaxine Conjugated estrogens may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.
Cevimeline Cevimeline Cevimeline may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Bendamustine Injection Bendamustine Injection The metabolism of Bendamustine can be decreased when combined with Conjugated estrogens.
Leucovorin Injection Leucovorin Injection The excretion of Leucovorin can be decreased when combined with Conjugated estrogens.
Flecainide Flecainide The metabolism of Flecainide can be decreased when combined with Conjugated estrogens.
Certolizumab Injection Certolizumab Injection The metabolism of Conjugated estrogens can be increased when combined with Certolizumab pegol.
Irinotecan Injection Irinotecan Injection The excretion of Conjugated estrogens can be decreased when combined with Irinotecan.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Praziquantel Praziquantel The metabolism of Praziquantel can be decreased when combined with Conjugated estrogens.
Methylnaltrexone Injection Methylnaltrexone Injection Conjugated estrogens may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Conjugated estrogens may increase the thrombogenic activities of Alemtuzumab.
Midazolam Midazolam Conjugated estrogens may decrease the excretion rate of Midazolam which could result in a higher serum level.
Dexrazoxane Injection Dexrazoxane Injection Conjugated estrogens may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.
Eltrombopag Eltrombopag Eltrombopag may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ibritumomab Injection Ibritumomab Injection Conjugated estrogens may increase the thrombogenic activities of Ibritumomab tiuxetan.
Milnacipran Milnacipran Conjugated estrogens may decrease the excretion rate of Milnacipran which could result in a higher serum level.
Plerixafor Injection Plerixafor Injection Conjugated estrogens may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Fesoterodine Fesoterodine Conjugated estrogens may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Betaxolol Betaxolol The metabolism of Conjugated estrogens can be decreased when combined with Betaxolol.
Prasugrel Prasugrel Conjugated estrogens may decrease the anticoagulant activities of Prasugrel.
Everolimus Everolimus The excretion of Conjugated estrogens can be decreased when combined with Everolimus.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Dronedarone Dronedarone The excretion of Conjugated estrogens can be decreased when combined with Dronedarone.
Pralatrexate Injection Pralatrexate Injection Conjugated estrogens may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection Conjugated estrogens may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Saxagliptin Saxagliptin The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Saxagliptin.
Telavancin Injection Telavancin Injection Conjugated estrogens may decrease the excretion rate of Telavancin which could result in a higher serum level.
Topotecan Topotecan Conjugated estrogens may decrease the excretion rate of Topotecan which could result in a higher serum level.
Ofatumumab Injection (Chronic Lymphocytic Leukemia) Ofatumumab Injection (Chronic Lymphocytic Leukemia) Conjugated estrogens may increase the thrombogenic activities of Ofatumumab.
Golimumab Injection Golimumab Injection The metabolism of Conjugated estrogens can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Conjugated estrogens.
Asenapine Asenapine The metabolism of Asenapine can be decreased when combined with Conjugated estrogens.
Pitavastatin Pitavastatin The excretion of Pitavastatin can be decreased when combined with Conjugated estrogens.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Conjugated estrogens.
Denosumab Injection Denosumab Injection Conjugated estrogens may increase the thrombogenic activities of Denosumab.
Dabigatran Dabigatran Conjugated estrogens may decrease the anticoagulant activities of Dabigatran.
Tocilizumab Injection Tocilizumab Injection The metabolism of Conjugated estrogens can be increased when combined with Tocilizumab.
Dalfampridine Dalfampridine Conjugated estrogens may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Cabazitaxel Injection Cabazitaxel Injection Cabazitaxel may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ustekinumab Injection Ustekinumab Injection Conjugated estrogens may increase the thrombogenic activities of Ustekinumab.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Acetaminophen Injection Acetaminophen Injection The metabolism of Acetaminophen can be decreased when combined with Conjugated estrogens.
Ipilimumab Injection Ipilimumab Injection Conjugated estrogens may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection Conjugated estrogens may decrease the excretion rate of Terbutaline which could result in a higher serum level.
Belimumab Injection Belimumab Injection Conjugated estrogens may increase the thrombogenic activities of Belimumab.
Azilsartan Azilsartan The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Azilsartan medoxomil.
Roflumilast Roflumilast Conjugated estrogens may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Linagliptin Linagliptin The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Linagliptin.
Rilpivirine Rilpivirine Rilpivirine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Telaprevir Telaprevir Glecaprevir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Abiraterone Abiraterone The serum concentration of Conjugated estrogens can be increased when it is combined with Abiraterone.
Rivaroxaban Rivaroxaban Conjugated estrogens may decrease the anticoagulant activities of Rivaroxaban.
Ticagrelor Ticagrelor Conjugated estrogens may decrease the anticoagulant activities of Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection Conjugated estrogens may increase the thrombogenic activities of Brentuximab vedotin.
Ruxolitinib Ruxolitinib Conjugated estrogens may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
Vandetanib Vandetanib Vandetanib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Clobazam Clobazam Conjugated estrogens may decrease the excretion rate of Clobazam which could result in a higher serum level.
Vemurafenib Vemurafenib The serum concentration of Conjugated estrogens can be increased when it is combined with Vemurafenib.
Vismodegib Vismodegib Vismodegib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Basiliximab Injection Basiliximab Injection Conjugated estrogens may increase the thrombogenic activities of Basiliximab.
Deferiprone Deferiprone Conjugated estrogens may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Conjugated estrogens.
Naloxone Injection Naloxone Injection Conjugated estrogens may decrease the excretion rate of Naloxone which could result in a higher serum level.
Ambrisentan Ambrisentan The excretion of Ambrisentan can be decreased when combined with Conjugated estrogens.
Eculizumab Injection Eculizumab Injection Conjugated estrogens may increase the thrombogenic activities of Eculizumab.
Fondaparinux Injection Fondaparinux Injection Conjugated estrogens may decrease the anticoagulant activities of Fondaparinux.
Pertuzumab Injection Pertuzumab Injection Conjugated estrogens may increase the thrombogenic activities of Pertuzumab.
Iloprost Iloprost Conjugated estrogens may decrease the anticoagulant activities of Iloprost.
Enzalutamide Enzalutamide The therapeutic efficacy of Conjugated estrogens can be decreased when used in combination with Enzalutamide.
Mirabegron Mirabegron Conjugated estrogens may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Regorafenib Regorafenib Regorafenib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Corticotropin, Repository Injection Corticotropin, Repository Injection The serum concentration of Corticotropin can be increased when it is combined with Conjugated estrogens.
Teriflunomide Teriflunomide The serum concentration of Conjugated estrogens can be decreased when it is combined with Teriflunomide.
Teduglutide Injection Teduglutide Injection Conjugated estrogens may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Alogliptin Alogliptin The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Alogliptin.
Ponatinib Ponatinib Ponatinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Conjugated estrogens.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection Conjugated estrogens may increase the thrombogenic activities of Trastuzumab emtansine.
Apixaban Apixaban Conjugated estrogens may decrease the anticoagulant activities of Apixaban.
Canagliflozin Canagliflozin Conjugated estrogens may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib Dabrafenib Dabrafenib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ospemifene Ospemifene The risk or severity of adverse effects can be increased when Conjugated estrogens is combined with Ospemifene.
Trametinib Trametinib Conjugated estrogens may decrease the excretion rate of Trametinib which could result in a higher serum level.
Dolutegravir Dolutegravir The excretion of Conjugated estrogens can be decreased when combined with Dolutegravir.
Afatinib Afatinib Afatinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Levomilnacipran Levomilnacipran Conjugated estrogens may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Ertapenem Injection Ertapenem Injection Conjugated estrogens may decrease the excretion rate of Ertapenem which could result in a higher serum level.
Vortioxetine Vortioxetine Conjugated estrogens may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
Perampanel Perampanel The metabolism of Perampanel can be decreased when combined with Conjugated estrogens.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Obinutuzumab Injection Obinutuzumab Injection Conjugated estrogens may increase the thrombogenic activities of Obinutuzumab.
Simeprevir Simeprevir The metabolism of Conjugated estrogens can be decreased when combined with Simeprevir.
Sofosbuvir Sofosbuvir Conjugated estrogens may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin The metabolism of Conjugated estrogens can be decreased when combined with Dapagliflozin.
Apremilast Apremilast The metabolism of Conjugated estrogens can be increased when combined with Apremilast.
Droxidopa Droxidopa Conjugated estrogens may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Ramucirumab Injection Ramucirumab Injection Conjugated estrogens may increase the thrombogenic activities of Ramucirumab.
Siltuximab Injection Siltuximab Injection The metabolism of Conjugated estrogens can be increased when combined with Siltuximab.
Vedolizumab Injection Vedolizumab Injection Conjugated estrogens may increase the thrombogenic activities of Vedolizumab.
Belinostat Injection Belinostat Injection The metabolism of Conjugated estrogens can be increased when combined with Belinostat.
Idelalisib Idelalisib The excretion of Conjugated estrogens can be decreased when combined with Idelalisib.
Testosterone Injection Testosterone Injection Testosterone may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Vorapaxar Vorapaxar Conjugated estrogens may decrease the anticoagulant activities of Vorapaxar.
Dulaglutide Injection Dulaglutide Injection Conjugated estrogens may increase the thrombogenic activities of Dulaglutide.
Pembrolizumab Injection Pembrolizumab Injection Conjugated estrogens may increase the thrombogenic activities of Pembrolizumab.
Edoxaban Edoxaban Conjugated estrogens may decrease the anticoagulant activities of Edoxaban.
Nivolumab Injection Nivolumab Injection Conjugated estrogens may increase the thrombogenic activities of Nivolumab.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The metabolism of Conjugated estrogens can be decreased when combined with Peginterferon beta-1a.
Olaparib Olaparib Olaparib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Blinatumomab Injection Blinatumomab Injection Conjugated estrogens may increase the thrombogenic activities of Blinatumomab.
Caspofungin Injection Caspofungin Injection The excretion of Caspofungin can be decreased when combined with Conjugated estrogens.
Methamphetamine Methamphetamine Conjugated estrogens may decrease the excretion rate of Metamfetamine which could result in a higher serum level.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Conjugated estrogens.
Pirfenidone Pirfenidone The metabolism of Pirfenidone can be decreased when combined with Conjugated estrogens.
Secukinumab Injection Secukinumab Injection The metabolism of Conjugated estrogens can be increased when combined with Secukinumab.
Palbociclib Palbociclib Palbociclib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Insulin Human Inhalation Insulin Human Inhalation The metabolism of Conjugated estrogens can be increased when combined with Insulin human.
Lenvatinib Lenvatinib The metabolism of Conjugated estrogens can be decreased when combined with Lenvatinib.
Dinutuximab Injection Dinutuximab Injection Conjugated estrogens may increase the thrombogenic activities of Dinutuximab.
Haloperidol Injection Haloperidol Injection The serum concentration of Haloperidol can be increased when it is combined with Conjugated estrogens.
Amiloride Amiloride Amiloride may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Macitentan Macitentan Conjugated estrogens may decrease the excretion rate of Macitentan which could result in a higher serum level.
Alirocumab Injection Alirocumab Injection Conjugated estrogens may increase the thrombogenic activities of Alirocumab.
Rolapitant Rolapitant Rolapitant may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Prednisolone Prednisolone The serum concentration of Prednisolone can be increased when it is combined with Conjugated estrogens.
Evolocumab Injection Evolocumab Injection Conjugated estrogens may increase the thrombogenic activities of Evolocumab.
Daclatasvir Daclatasvir Daclatasvir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Penicillin G Procaine Injection Penicillin G Procaine Injection Conjugated estrogens may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Eluxadoline Eluxadoline The serum concentration of Eluxadoline can be increased when it is combined with Conjugated estrogens.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The metabolism of Conjugated estrogens can be increased when combined with Insulin degludec.
Cobimetinib Cobimetinib The excretion of Cobimetinib can be decreased when combined with Conjugated estrogens.
Mepolizumab Injection Mepolizumab Injection Conjugated estrogens may increase the thrombogenic activities of Mepolizumab.
Elotuzumab Injection Elotuzumab Injection Conjugated estrogens may increase the thrombogenic activities of Elotuzumab.
Daratumumab Injection Daratumumab Injection Conjugated estrogens may increase the thrombogenic activities of Daratumumab.
Osimertinib Osimertinib The serum concentration of Conjugated estrogens can be decreased when it is combined with Osimertinib.
Alectinib Alectinib Alectinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ixazomib Ixazomib Conjugated estrogens may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Necitumumab Injection Necitumumab Injection Conjugated estrogens may increase the thrombogenic activities of Necitumumab.
Lesinurad Lesinurad Conjugated estrogens may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Dexamethasone Injection Dexamethasone Injection The serum concentration of Dexamethasone can be increased when it is combined with Conjugated estrogens.
Reslizumab Injection Reslizumab Injection Conjugated estrogens may increase the thrombogenic activities of Reslizumab.
Defibrotide Injection Defibrotide Injection Conjugated estrogens may decrease the anticoagulant activities of Defibrotide.
Ixekizumab Injection Ixekizumab Injection Conjugated estrogens may increase the thrombogenic activities of Ixekizumab.
Brivaracetam Injection Brivaracetam Injection Conjugated estrogens may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
Venetoclax Venetoclax Venetoclax may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cobicistat Cobicistat Cobicistat may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Selexipag Selexipag The excretion of Selexipag can be decreased when combined with Conjugated estrogens.
Obeticholic Acid Obeticholic Acid The metabolism of Conjugated estrogens can be decreased when combined with Obeticholic acid.
Atezolizumab Injection Atezolizumab Injection Conjugated estrogens may increase the thrombogenic activities of Atezolizumab.
Furosemide Injection Furosemide Injection The therapeutic efficacy of Furosemide can be decreased when used in combination with Conjugated estrogens.
Olaratumab Injection Olaratumab Injection Conjugated estrogens may increase the thrombogenic activities of Olaratumab.
Rucaparib Rucaparib The excretion of Conjugated estrogens can be decreased when combined with Rucaparib.
Bezlotoxumab Injection Bezlotoxumab Injection Conjugated estrogens may increase the thrombogenic activities of Bezlotoxumab.
Lixisenatide Injection Lixisenatide Injection Conjugated estrogens may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Avelumab Injection Avelumab Injection Conjugated estrogens may increase the thrombogenic activities of Avelumab.
Brodalumab Injection Brodalumab Injection Conjugated estrogens may increase the thrombogenic activities of Brodalumab.
Brigatinib Brigatinib Brigatinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Conjugated estrogens.
Dupilumab Injection Dupilumab Injection Conjugated estrogens may increase the thrombogenic activities of Dupilumab.
Deutetrabenazine Deutetrabenazine Conjugated estrogens may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
Valbenazine Valbenazine Conjugated estrogens may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Deflazacort Deflazacort The serum concentration of Deflazacort can be increased when it is combined with Conjugated estrogens.
Safinamide Safinamide Safinamide may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ocrelizumab Injection Ocrelizumab Injection Conjugated estrogens may increase the thrombogenic activities of Ocrelizumab.
Edaravone Injection Edaravone Injection The excretion of Edaravone can be decreased when combined with Conjugated estrogens.
Durvalumab Injection Durvalumab Injection Conjugated estrogens may increase the thrombogenic activities of Durvalumab.
Naldemedine Naldemedine Conjugated estrogens may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Sarilumab Injection Sarilumab Injection Conjugated estrogens may increase the thrombogenic activities of Sarilumab.
Midostaurin Midostaurin The metabolism of Conjugated estrogens can be decreased when combined with Midostaurin.
Guselkumab Injection Guselkumab Injection Conjugated estrogens may increase the thrombogenic activities of Guselkumab.
Enasidenib Enasidenib The metabolism of Conjugated estrogens can be decreased when combined with Enasidenib.
Inotuzumab Ozogamicin Injection Inotuzumab Ozogamicin Injection Conjugated estrogens may increase the thrombogenic activities of Inotuzumab ozogamicin.
Benznidazole Benznidazole Conjugated estrogens may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Delafloxacin Delafloxacin Conjugated estrogens may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Abemaciclib Abemaciclib Abemaciclib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Betrixaban Betrixaban Conjugated estrogens may decrease the anticoagulant activities of Betrixaban.
Benralizumab Injection Benralizumab Injection Conjugated estrogens may increase the thrombogenic activities of Benralizumab.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection Conjugated estrogens may increase the thrombogenic activities of Gemtuzumab ozogamicin.
Letermovir Letermovir The excretion of Conjugated estrogens can be decreased when combined with Letermovir.
Ertugliflozin Ertugliflozin Ertugliflozin may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Buprenorphine Injection Buprenorphine Injection Buprenorphine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Apalutamide Apalutamide The excretion of Conjugated estrogens can be decreased when combined with Apalutamide.
Ibalizumab-uiyk Injection Ibalizumab-uiyk Injection Conjugated estrogens may increase the thrombogenic activities of Ibalizumab.
Penicillamine Penicillamine The excretion of Penicillamine can be decreased when combined with Conjugated estrogens.
Fostamatinib Fostamatinib Fostamatinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Tildrakizumab-asmn injection Tildrakizumab-asmn injection Conjugated estrogens may increase the thrombogenic activities of Tildrakizumab.
Erenumab-aooe Injection Erenumab-aooe Injection Conjugated estrogens may increase the thrombogenic activities of Erenumab.
Avatrombopag Avatrombopag Avatrombopag may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Baricitinib Baricitinib Baricitinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Burosumab-twza Injection Burosumab-twza Injection Conjugated estrogens may increase the thrombogenic activities of Burosumab.
Lofexidine Lofexidine The metabolism of Lofexidine can be decreased when combined with Conjugated estrogens.
Plazomicin Injection Plazomicin Injection Conjugated estrogens may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Conjugated estrogens.
Ivosidenib Ivosidenib The excretion of Conjugated estrogens can be decreased when combined with Ivosidenib.
Elagolix Elagolix The excretion of Elagolix can be decreased when combined with Conjugated estrogens.
Cannabidiol Cannabidiol Cannabidiol may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cemiplimab-rwlc Injection Cemiplimab-rwlc Injection Conjugated estrogens may increase the thrombogenic activities of Cemiplimab.
Dacomitinib Dacomitinib Dacomitinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Galcanezumab-gnlm Injection Galcanezumab-gnlm Injection Conjugated estrogens may increase the thrombogenic activities of Galcanezumab.
Mogamulizumab-kpkc Injection Mogamulizumab-kpkc Injection Conjugated estrogens may increase the thrombogenic activities of Mogamulizumab.
Stiripentol Stiripentol The metabolism of Conjugated estrogens can be decreased when combined with Stiripentol.
Gilteritinib Gilteritinib Gilteritinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Glasdegib Glasdegib Glasdegib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Rifamycin Rifamycin The metabolism of Conjugated estrogens can be decreased when combined with Rifamycin.
Prucalopride Prucalopride Conjugated estrogens may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection Conjugated estrogens may increase the thrombogenic activities of Ravulizumab.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Conjugated estrogens can be increased when combined with Emapalumab.
Romosozumab-aqqg Injection Romosozumab-aqqg Injection Conjugated estrogens may increase the thrombogenic activities of Romosozumab.
Acyclovir Ophthalmic Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection Conjugated estrogens may increase the thrombogenic activities of Caplacizumab.
Esomeprazole Injection Esomeprazole Injection The excretion of Conjugated estrogens can be decreased when combined with Esomeprazole.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection Conjugated estrogens may increase the thrombogenic activities of Risankizumab.
Polatuzumab vedotin-piiq Injection Polatuzumab vedotin-piiq Injection Conjugated estrogens may increase the thrombogenic activities of Polatuzumab vedotin.
Solriamfetol Solriamfetol Conjugated estrogens may decrease the excretion rate of Solriamfetol which could result in a higher serum level.
Selinexor Selinexor The excretion of Conjugated estrogens can be decreased when combined with Selinexor.
Darolutamide Darolutamide The serum concentration of Conjugated estrogens can be increased when it is combined with Darolutamide.
Triclabendazole Triclabendazole The metabolism of Conjugated estrogens can be decreased when combined with Triclabendazole.
Pexidartinib Pexidartinib The excretion of Conjugated estrogens can be decreased when combined with Pexidartinib.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Conjugated estrogens.
Pitolisant Pitolisant The serum concentration of Conjugated estrogens can be decreased when it is combined with Pitolisant.
Fedratinib Fedratinib Fedratinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Phenytoin Injection Phenytoin Injection The therapeutic efficacy of Phenytoin can be decreased when used in combination with Conjugated estrogens.
Fosphenytoin Injection Fosphenytoin Injection The therapeutic efficacy of Conjugated estrogens can be decreased when used in combination with Fosphenytoin.
Brolucizumab-dbll Injection Brolucizumab-dbll Injection Conjugated estrogens may increase the thrombogenic activities of Brolucizumab.
Fam-trastuzumab deruxtecan-nxki Injection Fam-trastuzumab deruxtecan-nxki Injection Conjugated estrogens may increase the thrombogenic activities of Trastuzumab deruxtecan.
Lasmiditan Lasmiditan The serum concentration of Conjugated estrogens can be increased when it is combined with Lasmiditan.
Bempedoic Acid Bempedoic Acid The excretion of Conjugated estrogens can be decreased when combined with Bempedoic acid.
Cenobamate Cenobamate The serum concentration of Conjugated estrogens can be decreased when it is combined with Cenobamate.
Isatuximab-irfc Injection Isatuximab-irfc Injection Conjugated estrogens may increase the thrombogenic activities of Isatuximab.
Teprotumumab-trbw Injection Teprotumumab-trbw Injection Conjugated estrogens may increase the thrombogenic activities of Teprotumumab.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Conjugated estrogens.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Conjugated estrogens.
Remdesivir Injection Remdesivir Injection The excretion of Remdesivir can be decreased when combined with Conjugated estrogens.
Sacituzumab govitecan-hziy Injection Sacituzumab govitecan-hziy Injection Conjugated estrogens may increase the thrombogenic activities of Sacituzumab govitecan.
Ripretinib Ripretinib Ripretinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Capmatinib Capmatinib The serum concentration of Conjugated estrogens can be increased when it is combined with Capmatinib.
Daratumumab and Hyaluronidase-fihj Injection Daratumumab and Hyaluronidase-fihj Injection The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Conjugated estrogens.
Luspatercept-aamt Injection Luspatercept-aamt Injection Conjugated estrogens may increase the thrombogenic activities of Luspatercept.
Fostemsavir Fostemsavir Fostemsavir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Conjugated estrogens.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection Conjugated estrogens may increase the thrombogenic activities of Belantamab mafodotin.
Tafasitamab-cxix Injection Tafasitamab-cxix Injection Conjugated estrogens may increase the thrombogenic activities of Tafasitamab.
Pralsetinib Pralsetinib Pralsetinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Opicapone Opicapone The metabolism of Conjugated estrogens can be decreased when combined with Opicapone.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Conjugated estrogens can be decreased when it is combined with Satralizumab.
Margetuximab-cmkb Injection Margetuximab-cmkb Injection Conjugated estrogens may increase the thrombogenic activities of Margetuximab.
Cabotegravir Cabotegravir The excretion of Conjugated estrogens can be decreased when combined with Cabotegravir.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Evinacumab-dgnb Injection Evinacumab-dgnb Injection Conjugated estrogens may increase the thrombogenic activities of Evinacumab.
Viloxazine Viloxazine Conjugated estrogens may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Aducanumab-avwa Injection Aducanumab-avwa Injection Conjugated estrogens may increase the thrombogenic activities of Aducanumab.
Anifrolumab-fnia Injection Anifrolumab-fnia Injection Conjugated estrogens may increase the thrombogenic activities of Anifrolumab.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Conjugated estrogens.
Fenoprofen Fenoprofen Fenoprofen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Indomethacin Indomethacin The excretion of Conjugated estrogens can be decreased when combined with Indomethacin.
Mefenamic Acid Mefenamic Acid Mefenamic acid may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Naproxen Naproxen Naproxen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Tolmetin Tolmetin Tolmetin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Sulindac Sulindac Sulindac may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Isotretinoin Isotretinoin Conjugated estrogens may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate Sucralfate Conjugated estrogens may decrease the excretion rate of Sucralfate which could result in a higher serum level.
Floxuridine Floxuridine Conjugated estrogens may decrease the excretion rate of Floxuridine which could result in a higher serum level.
Metaxalone Metaxalone Conjugated estrogens may decrease the excretion rate of Metaxalone which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection Methotrexate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Primidone Primidone The metabolism of Conjugated estrogens can be increased when combined with Primidone.
Chlorpromazine Chlorpromazine The metabolism of Chlorpromazine can be decreased when combined with Conjugated estrogens.
Diazepam Diazepam Conjugated estrogens may decrease the excretion rate of Diazepam which could result in a higher serum level.
Oxazepam Oxazepam Conjugated estrogens may decrease the excretion rate of Oxazepam which could result in a higher serum level.
Flurazepam Flurazepam Conjugated estrogens may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate Clorazepate Conjugated estrogens may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
Lorazepam Lorazepam Lorazepam may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Carmustine Carmustine The metabolism of Conjugated estrogens can be decreased when combined with Carmustine.
Amantadine Amantadine Conjugated estrogens may decrease the excretion rate of Amantadine which could result in a higher serum level.
Codeine Codeine Conjugated estrogens may decrease the excretion rate of Codeine which could result in a higher serum level.
Tranylcypromine Tranylcypromine The metabolism of Conjugated estrogens can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine Conjugated estrogens may decrease the excretion rate of Phenelzine which could result in a higher serum level.
Tetracycline Tetracycline The excretion of Tetracycline can be decreased when combined with Conjugated estrogens.
Minocycline Minocycline The excretion of Conjugated estrogens can be decreased when combined with Minocycline.
Trifluoperazine Trifluoperazine The metabolism of Trifluoperazine can be decreased when combined with Conjugated estrogens.
Bleomycin Bleomycin Conjugated estrogens may decrease the excretion rate of Bleomycin which could result in a higher serum level.
Sulfadiazine Sulfadiazine Conjugated estrogens may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.
Benztropine Benztropine Benzatropine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Maprotiline Maprotiline The metabolism of Maprotiline can be decreased when combined with Conjugated estrogens.
Ibuprofen Ibuprofen The excretion of Conjugated estrogens can be decreased when combined with Ibuprofen.
Orphenadrine Orphenadrine The metabolism of Conjugated estrogens can be decreased when combined with Orphenadrine.
Perphenazine Perphenazine The metabolism of Perphenazine can be decreased when combined with Conjugated estrogens.
Azathioprine Azathioprine The metabolism of Azathioprine can be decreased when combined with Conjugated estrogens.
Methylphenidate Methylphenidate Conjugated estrogens may decrease the excretion rate of Methylphenidate which could result in a higher serum level.
Amoxapine Amoxapine The serum concentration of Amoxapine can be increased when it is combined with Conjugated estrogens.
Sulfasalazine Sulfasalazine Sulfasalazine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Hydrocortisone Hydrocortisone The serum concentration of Hydrocortisone can be increased when it is combined with Conjugated estrogens.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Carbamazepine Carbamazepine The metabolism of Conjugated estrogens can be increased when combined with Carbamazepine.
Methyldopa Methyldopa Conjugated estrogens may decrease the excretion rate of Methyldopa which could result in a higher serum level.
Clonidine Clonidine The metabolism of Clonidine can be decreased when combined with Conjugated estrogens.
Hydralazine Hydralazine Conjugated estrogens may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Cimetidine Cimetidine The excretion of Cimetidine can be decreased when combined with Conjugated estrogens.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Warfarin Warfarin The metabolism of Warfarin can be decreased when combined with Conjugated estrogens.
Clonazepam Clonazepam Conjugated estrogens may decrease the excretion rate of Clonazepam which could result in a higher serum level.
Promethazine Promethazine Conjugated estrogens may decrease the excretion rate of Promethazine which could result in a higher serum level.
Meclofenamate Meclofenamate The therapeutic efficacy of Conjugated estrogens can be decreased when used in combination with Meclofenamic acid.
Nitrofurantoin Nitrofurantoin The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Conjugated estrogens.
Griseofulvin Griseofulvin The metabolism of Conjugated estrogens can be increased when combined with Griseofulvin.
Digoxin Digoxin Conjugated estrogens may decrease the excretion rate of Digoxin which could result in a higher serum level.
Chloroquine Chloroquine Conjugated estrogens may decrease the excretion rate of Chloroquine which could result in a higher serum level.
Quinine Quinine The metabolism of Conjugated estrogens can be decreased when combined with Quinine.
Triamterene Triamterene The metabolism of Triamterene can be decreased when combined with Conjugated estrogens.
Chlorothiazide Chlorothiazide Chlorothiazide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Chlorthalidone Chlorthalidone Chlorthalidone may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone Metolazone Conjugated estrogens may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Secobarbital Secobarbital The metabolism of Secobarbital can be increased when combined with Conjugated estrogens.
Desipramine Desipramine Conjugated estrogens may decrease the excretion rate of Desipramine which could result in a higher serum level.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Conjugated estrogens.
Imipramine Imipramine The metabolism of Conjugated estrogens can be decreased when combined with Imipramine.
Probenecid Probenecid The excretion of Conjugated estrogens can be decreased when combined with Probenecid.
Quinidine Quinidine The metabolism of Quinidine can be decreased when combined with Conjugated estrogens.
Procainamide Procainamide Conjugated estrogens may decrease the excretion rate of Procainamide which could result in a higher serum level.
Isoniazid Isoniazid The metabolism of Isoniazid can be decreased when combined with Conjugated estrogens.
Pyrazinamide Pyrazinamide Conjugated estrogens may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.
Rifampin Rifampin The metabolism of Conjugated estrogens can be increased when combined with Rifampicin.
Disopyramide Disopyramide The metabolism of Conjugated estrogens can be decreased when combined with Disopyramide.
Valproic Acid Valproic Acid The excretion of Valproic acid can be decreased when combined with Conjugated estrogens.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Conjugated estrogens.
Butabarbital Butabarbital Butabarbital may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Levothyroxine Levothyroxine The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Conjugated estrogens.
Liothyronine Liothyronine The therapeutic efficacy of Conjugated estrogens can be decreased when used in combination with Liothyronine.
Methimazole Methimazole The metabolism of Conjugated estrogens can be decreased when combined with Methimazole.
Chlorpropamide Chlorpropamide The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Conjugated estrogens.
Tolbutamide Tolbutamide The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Conjugated estrogens.
Tolazamide Tolazamide The therapeutic efficacy of Tolazamide can be decreased when used in combination with Conjugated estrogens.
Dinoprostone Dinoprostone The excretion of Dinoprostone can be decreased when combined with Conjugated estrogens.
Cyclobenzaprine Cyclobenzaprine The metabolism of Cyclobenzaprine can be decreased when combined with Conjugated estrogens.
Baclofen Baclofen Baclofen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ethambutol Ethambutol Conjugated estrogens may decrease the excretion rate of Ethambutol which could result in a higher serum level.
Methyclothiazide Methyclothiazide Methyclothiazide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Hydrochlorothiazide Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Dantrolene Dantrolene The therapeutic efficacy of Dantrolene can be decreased when used in combination with Conjugated estrogens.
Chlorzoxazone Chlorzoxazone The metabolism of Chlorzoxazone can be decreased when combined with Conjugated estrogens.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The metabolism of Propranolol can be decreased when combined with Conjugated estrogens.
Nortriptyline Nortriptyline The serum concentration of Nortriptyline can be increased when it is combined with Conjugated estrogens.
Spironolactone Spironolactone Spironolactone may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection Amphotericin B Injection Amphotericin B may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Mercaptopurine Mercaptopurine The excretion of Mercaptopurine can be decreased when combined with Conjugated estrogens.
Phytonadione Phytonadione Conjugated estrogens may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Nadolol Nadolol Conjugated estrogens may decrease the excretion rate of Nadolol which could result in a higher serum level.
Allopurinol Allopurinol The excretion of Allopurinol can be decreased when combined with Conjugated estrogens.
Flavoxate Flavoxate Conjugated estrogens may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Fluorouracil Injection Fluorouracil Injection The metabolism of Fluorouracil can be decreased when combined with Conjugated estrogens.
Colchicine Colchicine Conjugated estrogens may decrease the excretion rate of Colchicine which could result in a higher serum level.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Dacarbazine Dacarbazine The metabolism of Dacarbazine can be decreased when combined with Conjugated estrogens.
Acetazolamide Acetazolamide Acetazolamide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Nystatin Nystatin The excretion of Conjugated estrogens can be decreased when combined with Nystatin.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ketoconazole Ketoconazole The metabolism of Conjugated estrogens can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel Conjugated estrogens may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Vincristine Injection Vincristine Injection The excretion of Conjugated estrogens can be decreased when combined with Vincristine.
Captopril Captopril The excretion of Captopril can be decreased when combined with Conjugated estrogens.
Dipyridamole Dipyridamole Conjugated estrogens may decrease the anticoagulant activities of Dipyridamole.
Vinblastine Vinblastine The excretion of Conjugated estrogens can be decreased when combined with Vinblastine.
Ethacrynic Acid Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Metoprolol Metoprolol Metoprolol may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Thiothixene Thiothixene The metabolism of Thiothixene can be decreased when combined with Conjugated estrogens.
Aspirin Aspirin Conjugated estrogens may decrease the anticoagulant activities of Acetylsalicylic acid.
Salsalate Salsalate Salsalate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Alprazolam Alprazolam Conjugated estrogens may decrease the excretion rate of Alprazolam which could result in a higher serum level.
Temazepam Temazepam Temazepam may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Triazolam Triazolam Conjugated estrogens may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dicyclomine Dicyclomine Conjugated estrogens may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Propantheline Propantheline Conjugated estrogens may decrease the excretion rate of Propantheline which could result in a higher serum level.
Trimethoprim Trimethoprim Conjugated estrogens may decrease the excretion rate of Trimethoprim which could result in a higher serum level.
Nifedipine Nifedipine The metabolism of Conjugated estrogens can be decreased when combined with Nifedipine.
Timolol Timolol Conjugated estrogens may decrease the excretion rate of Timolol which could result in a higher serum level.
Verapamil Verapamil The metabolism of Conjugated estrogens can be decreased when combined with Verapamil.
Pindolol Pindolol Conjugated estrogens may decrease the excretion rate of Pindolol which could result in a higher serum level.
Cisplatin Injection Cisplatin Injection Conjugated estrogens may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal Diflunisal may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Piroxicam Piroxicam Piroxicam may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Bumetanide Bumetanide Conjugated estrogens may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.
Streptozocin Streptozocin The metabolism of Conjugated estrogens can be increased when combined with Streptozocin.
Etoposide Etoposide The metabolism of Etoposide can be decreased when combined with Conjugated estrogens.
Glyburide Glyburide The therapeutic efficacy of Conjugated estrogens can be decreased when used in combination with Glyburide.
Glipizide Glipizide The therapeutic efficacy of Glipizide can be decreased when used in combination with Conjugated estrogens.
Indapamide Indapamide Conjugated estrogens may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy.
Amoxicillin Amoxicillin Conjugated estrogens may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Nafcillin Injection Nafcillin Injection The metabolism of Conjugated estrogens can be increased when combined with Nafcillin.
Oxacillin Injection Oxacillin Injection Conjugated estrogens may decrease the excretion rate of Oxacillin which could result in a higher serum level.
Pentoxifylline Pentoxifylline The metabolism of Pentoxifylline can be decreased when combined with Conjugated estrogens.
Pentamidine Injection Pentamidine Injection Pentamidine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ceftriaxone Injection Ceftriaxone Injection The excretion of Conjugated estrogens can be decreased when combined with Ceftriaxone.
Labetalol Labetalol Conjugated estrogens may decrease the excretion rate of Labetalol which could result in a higher serum level.
Auranofin Auranofin Conjugated estrogens may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Leuprolide may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Gemfibrozil Gemfibrozil The metabolism of Conjugated estrogens can be decreased when combined with Gemfibrozil.
Guanabenz Guanabenz The metabolism of Guanabenz can be decreased when combined with Conjugated estrogens.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ketoprofen Ketoprofen Ketoprofen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Conjugated estrogens.
Enalapril Enalapril The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Enalapril.
Flurbiprofen Flurbiprofen Flurbiprofen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Amiodarone Amiodarone The metabolism of Amiodarone can be decreased when combined with Conjugated estrogens.
Aztreonam Injection Aztreonam Injection Conjugated estrogens may decrease the excretion rate of Aztreonam which could result in a higher serum level.
Buspirone Buspirone Conjugated estrogens may decrease the excretion rate of Buspirone which could result in a higher serum level.
Lovastatin Lovastatin The excretion of Conjugated estrogens can be decreased when combined with Lovastatin.
Ciprofloxacin Ciprofloxacin The metabolism of Conjugated estrogens can be decreased when combined with Ciprofloxacin.
Mesalamine Mesalamine Mesalazine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Diclofenac Diclofenac Diclofenac may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Fluoxetine Fluoxetine The metabolism of Fluoxetine can be decreased when combined with Conjugated estrogens.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The metabolism of Conjugated estrogens can be decreased when combined with Interferon alfa-2b.
Clozapine Clozapine The metabolism of Clozapine can be decreased when combined with Conjugated estrogens.
Estazolam Estazolam Conjugated estrogens may decrease the excretion rate of Estazolam which could result in a higher serum level.
Ofloxacin Ofloxacin The metabolism of Conjugated estrogens can be decreased when combined with Ofloxacin.
Didanosine Didanosine Conjugated estrogens may decrease the excretion rate of Didanosine which could result in a higher serum level.
Pentostatin Injection Pentostatin Injection Conjugated estrogens may decrease the excretion rate of Pentostatin which could result in a higher serum level.
Benazepril Benazepril The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Benazepril.
Etodolac Etodolac Etodolac may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Fosinopril Fosinopril The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Fosinopril.
Nabumetone Nabumetone Nabumetone may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Pravastatin Pravastatin Pravastatin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Quinapril Quinapril The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Quinapril.
Ramipril Ramipril The risk or severity of angioedema can be increased when Ramipril is combined with Conjugated estrogens.
Simvastatin Simvastatin The excretion of Simvastatin can be decreased when combined with Conjugated estrogens.
Lisinopril Lisinopril The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Lisinopril.
Oxaprozin Oxaprozin Oxaprozin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Bisoprolol Bisoprolol Conjugated estrogens may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Zolpidem Zolpidem The metabolism of Zolpidem can be decreased when combined with Conjugated estrogens.
Isradipine Isradipine Isradipine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Omeprazole Omeprazole Omeprazole may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Fluvastatin Fluvastatin The excretion of Conjugated estrogens can be decreased when combined with Fluvastatin.
Venlafaxine Venlafaxine Venlafaxine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Fluvoxamine Fluvoxamine The metabolism of Conjugated estrogens can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone Nefazodone may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Lamotrigine Lamotrigine The therapeutic efficacy of Lamotrigine can be decreased when used in combination with Conjugated estrogens.
Losartan Losartan The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Losartan.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Tramadol Tramadol Tramadol may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Carboplatin Injection Carboplatin Injection Carboplatin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Moexipril Moexipril The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Moexipril.
Lansoprazole Lansoprazole The excretion of Conjugated estrogens can be decreased when combined with Lansoprazole.
Alprostadil Urogenital Alprostadil Urogenital The excretion of Alprostadil can be decreased when combined with Conjugated estrogens.
Ifosfamide Injection Ifosfamide Injection Conjugated estrogens may decrease the excretion rate of Ifosfamide which could result in a higher serum level.
Nicardipine Nicardipine The excretion of Conjugated estrogens can be decreased when combined with Nicardipine.
Bupropion Bupropion Conjugated estrogens may decrease the excretion rate of Bupropion which could result in a higher serum level.
Ticlopidine Ticlopidine The metabolism of Conjugated estrogens can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir Saquinavir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Metformin Metformin Conjugated estrogens may decrease the excretion rate of Metformin which could result in a higher serum level.
Dalteparin Injection Dalteparin Injection Conjugated estrogens may decrease the anticoagulant activities of Dalteparin.
Nisoldipine Nisoldipine Conjugated estrogens may decrease the excretion rate of Nisoldipine which could result in a higher serum level.
Lamivudine Lamivudine Conjugated estrogens may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Riluzole Riluzole The metabolism of Riluzole can be decreased when combined with Conjugated estrogens.
Acarbose Acarbose Acarbose may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Glimepiride Glimepiride The therapeutic efficacy of Glimepiride can be decreased when used in combination with Conjugated estrogens.
Anastrozole Anastrozole The therapeutic efficacy of Anastrozole can be decreased when used in combination with Conjugated estrogens.
Gemcitabine Injection Gemcitabine Injection Conjugated estrogens may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Indinavir Indinavir The excretion of Conjugated estrogens can be decreased when combined with Indinavir.
Ritonavir Ritonavir The serum concentration of Ritonavir can be increased when it is combined with Conjugated estrogens.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Meropenem Injection Meropenem Injection Conjugated estrogens may decrease the excretion rate of Meropenem which could result in a higher serum level.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Conjugated estrogens.
Zafirlukast Zafirlukast The metabolism of Conjugated estrogens can be decreased when combined with Zafirlukast.
Fosfomycin Fosfomycin Conjugated estrogens may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Mirtazapine Mirtazapine The metabolism of Mirtazapine can be decreased when combined with Conjugated estrogens.
Trandolapril Trandolapril The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Trandolapril.
Topiramate Topiramate Topiramate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Zileuton Zileuton The metabolism of Zileuton can be decreased when combined with Conjugated estrogens.
Valsartan Valsartan The risk or severity of angioedema can be increased when Valsartan is combined with Conjugated estrogens.
Insulin Lispro Injection Insulin Lispro Injection The metabolism of Conjugated estrogens can be increased when combined with Insulin lispro.
Pramipexole Pramipexole Conjugated estrogens may decrease the excretion rate of Pramipexole which could result in a higher serum level.
Nelfinavir Nelfinavir Nelfinavir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Fexofenadine Fexofenadine The excretion of Fexofenadine can be decreased when combined with Conjugated estrogens.
Carvedilol Carvedilol The metabolism of Carvedilol can be decreased when combined with Conjugated estrogens.
Nilutamide Nilutamide Conjugated estrogens may decrease the excretion rate of Nilutamide which could result in a higher serum level.
Flutamide Flutamide The metabolism of Flutamide can be decreased when combined with Conjugated estrogens.
Selegiline Selegiline The metabolism of Selegiline can be decreased when combined with Conjugated estrogens.
Propafenone Propafenone The metabolism of Propafenone can be decreased when combined with Conjugated estrogens.
Raloxifene Raloxifene The excretion of Raloxifene can be decreased when combined with Conjugated estrogens.
Tamsulosin Tamsulosin Conjugated estrogens may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
Ropinirole Ropinirole The risk or severity of adverse effects can be increased when Conjugated estrogens is combined with Ropinirole.
Quetiapine Quetiapine Conjugated estrogens may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cetirizine Cetirizine Conjugated estrogens may decrease the excretion rate of Cetirizine which could result in a higher serum level.
Paroxetine Paroxetine The metabolism of Paroxetine can be decreased when combined with Conjugated estrogens.
Palivizumab Injection Palivizumab Injection Conjugated estrogens may increase the thrombogenic activities of Palivizumab.
Tolcapone Tolcapone Conjugated estrogens may decrease the excretion rate of Tolcapone which could result in a higher serum level.
Citalopram Citalopram The metabolism of Conjugated estrogens can be decreased when combined with Citalopram.
Capecitabine Capecitabine Conjugated estrogens may decrease the excretion rate of Capecitabine which could result in a higher serum level.
Efavirenz Efavirenz The metabolism of Conjugated estrogens can be decreased when combined with Efavirenz.
Abacavir Abacavir Conjugated estrogens may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil Sildenafil The excretion of Conjugated estrogens can be decreased when combined with Sildenafil.
Trastuzumab Injection Trastuzumab Injection Conjugated estrogens may increase the thrombogenic activities of Trastuzumab.
Celecoxib Celecoxib Celecoxib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Rosiglitazone Rosiglitazone The metabolism of Conjugated estrogens can be decreased when combined with Rosiglitazone.
Tolterodine Tolterodine Conjugated estrogens may decrease the excretion rate of Tolterodine which could result in a higher serum level.
Thalidomide Thalidomide Conjugated estrogens may increase the thrombogenic activities of Thalidomide.
Oseltamivir Oseltamivir The excretion of Conjugated estrogens can be decreased when combined with Oseltamivir.
Balsalazide Balsalazide Balsalazide may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Nateglinide Nateglinide Conjugated estrogens may decrease the excretion rate of Nateglinide which could result in a higher serum level.
Rabeprazole Rabeprazole Rabeprazole may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Terbinafine Terbinafine The metabolism of Terbinafine can be decreased when combined with Conjugated estrogens.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists